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Abstract: ABSTRACT 
Background: Achilles tendon pathologies may alter the coordinative 
strategies of synergistic calf muscles. We hypothesized that both surface 
electromyography and positron emission tomography would reveal 
differences between symptomatic and asymptomatic legs in Achilles 
tendinopathy patients and between healthy controls. 
Methods: Eleven subjects with unilateral chronic Achilles tendon pain (28 
yr) and eleven matched controls (28 yr) were studied for triceps surae 
and flexor hallucis longus muscle activity in response to repetitive 
isometric plantarflexion tasks performed at 30% of maximal voluntary 
contraction using surface electromyography and glucose uptake using 
positron emission tomography. Additionally, Achilles tendon glucose 
uptake was quantified.   
Findings: Normalized myoelectric activity of soleus was higher (P<0.05) 
in the symptomatic leg versus the contralateral and control legs despite 
lower absolute force level maintained (P<0.005). Electromyography 
amplitude of flexor hallucis longus was also greater on the symptomatic 
side compared to the healthy leg (P<0.05). Both the symptomatic and 
asymptomatic legs tended to have higher glucose uptake compared to the 
control legs (overall effect size: 0.9 and 1.3, respectively). Achilles 
tendon glucose uptake was greater in both legs of the patient group 
(P<0.05) compared to controls. Maximal plantarflexion force was ~14% 
greater in the healthier leg compared to the injured leg in the patient 
group. 
Interpretations: While the electromyography showed greater relative 
amplitude in the symptomatic leg, the results based on muscle glucose 
uptake suggested relatively similar behavior of both legs in the patient 
group. Higher glucose uptake in the symptomatic Achilles tendon suggests 
a higher metabolic demand.  
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ABSTRACT 27 
Background: Achilles tendon pathologies may alter the coordinative strategies of synergistic calf 28 
muscles. We hypothesized that both surface electromyography and positron emission 29 
tomography would reveal differences between symptomatic and asymptomatic legs in Achilles 30 
tendinopathy patients and between healthy controls. 31 
Methods: Eleven subjects with unilateral chronic Achilles tendon pain (28 yr) and eleven 32 
matched controls (28 yr) were studied for triceps surae and flexor hallucis longus muscle 33 
activity in response to repetitive isometric plantarflexion tasks performed at 30% of maximal 34 
voluntary contraction using surface electromyography and glucose uptake using positron 35 
emission tomography. Additionally, Achilles tendon glucose uptake was quantified.   36 
Findings: Normalized myoelectric activity of soleus was higher (P<0.05) in the symptomatic leg 37 
versus the contralateral and control legs despite lower absolute force level maintained 38 
(P<0.005). Electromyography amplitude of flexor hallucis longus was also greater on the 39 
symptomatic side compared to the healthy leg (P<0.05). Both the symptomatic and 40 
asymptomatic legs tended to have higher glucose uptake compared to the control legs (overall 41 
effect size: 0.9 and 1.3, respectively). Achilles tendon glucose uptake was greater in both legs of 42 
the patient group (P<0.05) compared to controls. Maximal plantarflexion force was ~14% 43 
greater in the healthier leg compared to the injured leg in the patient group. 44 
Interpretations: While the electromyography showed greater relative amplitude in the 45 
symptomatic leg, the results based on muscle glucose uptake suggested relatively similar 46 
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behavior of both legs in the patient group. Higher glucose uptake in the symptomatic Achilles 47 
tendon suggests a higher metabolic demand.  48 
 49 
Keywords: Biomechanics; Triceps surae; Achilles tendon; Glucose uptake; Tendinopathy; [18F]-50 
Fluorodeoxyglucose  51 
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INTRODUCTION 52 
The Achilles tendon (AT) is among the strongest tendons in the human body (Józsa & Kannus 53 
1997; Kvist, 1994). Despite its strength, the AT is susceptible to overuse injuries which, 54 
accompanied by tendon pain, impair function of the calf muscle-tendon unit (Silbernagel et al., 55 
2006). Furthermore, it may affect the muscle activation strategies of the individual 56 
compartments of the triceps surae (TS) muscle group, and other ankle plantarflexors (Mafi et 57 
al., 2001; Roos et al., 2004).  58 
Previous studies have established that the relative contribution within different compartments 59 
of the TS muscle group is inhomogeneous. Specifically, significant differences in the 60 
mediolateral forces within the Achilles tendon have been reported depending on how TS 61 
components were loaded (Arndt et al., 1999). The force contribution of various TS components 62 
also depends on muscle length since small changes in gastrocnemius length results in major 63 
changes in soleus and gastrocnemius electromyography (EMG), torque, and force (Arndt et al., 64 
1998; Cresswell et al., 1995).  65 
Past in-vivo studies have demonstrated considerable individual variation in the use of different 66 
plantarflexors in healthy individuals, displaying either low or high flexor hallucis longus (FHL) 67 
activation with corresponding tissue movement (Bojsen-Moller et al., 2010; Finni et al., 2003). 68 
Finni et al. (2006) showed that patients recovering from complete Achilles tendon rupture 69 
increased the contribution of FHL to motor tasks in their healthy and affected legs during 70 
rehabilitation. These observations lead the authors to hypothesize that this coordination 71 
strategy may contribute to Achilles tendon injuries since the FHL is an important deep 72 
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plantarflexor muscle (Klein et al. 1996). For this reason, and because the FHL is suitable for both 73 
PET and SEMG, we sought to further examine possible individual variations and the role of FHL 74 
during a plantarflexion task.   75 
While muscle coordination can readily be assessed using surface EMG (SEMG), it only provides 76 
information about activity of the superficial muscles, which may not represent that of the 77 
whole muscle volume (Knight & Kamen 2005). Therefore, MRI and ultrasonography have been 78 
used to study tissue movement within the muscle (Bojsen-Moller et al., 2010; Finni et al. 2006; 79 
Huijing et al., 2011). Alternatively, positron emission tomography (PET) can be used to non-80 
invasively investigate muscle glucose metabolism and thereby muscle metabolic activation 81 
(Nuutila & Kalliokoski 2000; Tashiro et al., 2008). High resolution PET has not only been 82 
employed to image and quantify glucose uptake as a result of exercise in skeletal muscles 83 
(Bojsen-Møller et al., 2010; Fujimoto et al., 2003; Hannukainen et al., 2005; Kemppainen et al., 84 
2002; Kalliokoski et al., 2007; Rudroff et al., 2013), but also in healthy and injured tendons 85 
(Bojsen-Møller et al., 2006; Huang et al., 2006; Kalliokoski et al., 2005). 86 
Since both SEMG and PET provide useful information regarding muscle-tendon behavior in 87 
health and disease, the overall purpose of this study was to investigate the electrical and 88 
metabolic activity patterns of various ankle plantarflexors in unilateral, chronic Achilles 89 
tendinopathy patients compared with healthy controls (CTRL). It was hypothesized that the 90 
relative contribution of different plantarflexors would differ between symptomatic (PAIN) and 91 
asymptomatic (NO-PAIN) legs, and further that it would differ from that of healthy controls. We 92 
also hypothesized that chronic tendon pain would lead to reduced maximal plantarflexion force 93 
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and glucose uptake, but similar SEMG, in the symptomatic leg in response to submaximal 94 
isometric exercise. In addition to muscle function, we also examined the Achilles tendon 95 
glucose uptake. 96 
 97 
MATERIALS AND METHODS 98 
Subjects  99 
Tendon pain group: The target age range was 18-35 years. Other inclusion criteria included 100 
unilateral Achilles tendon pain for at least past 6 weeks (Bashford et al. 2008; Józsa & Kannus 101 
1997) and absence of other major leg injury. Twenty Achilles tendon pain patients responded to 102 
the public recruitment advertisements for the study. After the screening process, eleven 103 
subjects - seven males and four females - were included in the study. The mean age (SD) of the 104 
participants was 28 (4) yr, height 174 (6) cm, and body mass 66 (6) kg. The subjects were 105 
physically active, recreational athletes (distance running, long jump, high jump, ice-hockey) who 106 
exercised on average 4.7 times a week the year prior to the study. Five patients had pain in the 107 
right Achilles tendon while the remaining six in the left leg. Average duration of symptoms at 108 
the time of baseline measurements was 9.8 (8) months (range: 2 - 25). Victorian Institute of 109 
Sports Assessment-Achilles (VISA-A) questionnaire, with a maximum possible score of 100, was 110 
used to measure the severity of Achilles tendinopathy (Robinson et al., 2001). Average VISA-A 111 
score in the subjects was 64 (18) (range: 27 - 86). 112 
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Healthy control group (CTRL): Eleven anthropometrically matched subjects, with no history of 113 
major leg injury or pain over the last year, were recruited by public announcements. The mean 114 
age, height, and body mass were 28 (4) yr, 173 (4) cm, and 67 (6) kg respectively. They reported 115 
to be physically active on average 2.4 times per week. 116 
The study protocol was approved by the Ethics Committee of the Hospital District of South-117 
Western Finland and conformed to the Declaration of Helsinki. All subjects gave informed 118 
written consent. 119 
Experimental Protocol  120 
Each subject took part in a series of tests, on a single day, at the Turku PET Centre, University of 121 
Turku, Finland. A schematic diagram of the experimental design is given in Fig. 1. Participants 122 
were required to fast for at least 8 hours prior to the PET scans. Before the study protocol, 123 
anthropometric measurements, such as body mass, height, and leg length, were obtained.  124 
Subject preparation comprised shaving, abrading, and cleaning of skin for surface 125 
electromyography (SEMG), electrode placement on legs, securing an electronic goniometer to 126 
the ankle. In addition, catheters were inserted into the antecubital veins of both arms: one for 127 
venous blood sampling and the other for [18F]-Fluorodeoxyglucose ([18F]-FDG) tracer injection. 128 
Subsequently subjects were positioned in the exercise apparatus for force and SEMG 129 
measurements. Subjects were familiarized with the equipment and the task by performing 130 
submaximal contractions from each leg. Maximal Voluntary Contraction (MVC) of ankle 131 
plantarflexors was then recorded unilaterally and the highest of the three trials was used to 132 
determine the submaximal force target for each leg.  133 
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Exercise protocol: Subjects performed the task while sitting on a seat placed on the floor with 134 
knees in full extension and hips flexed at right angle (Fig. 2). Exercise protocol consisted of sets 135 
of five unilateral submaximal, isometric voluntary contractions, at 30% of respective MVC, 136 
lasting five seconds with a 5-second rest. Subjects were able to watch both the target force and 137 
the actual force exertion on a monitor display. Following two sets of warm up contractions for 138 
both legs, ~150 MBq of [18F]-FDG tracer was infused after which the subjects performed 8 more 139 
sets with each leg, alternatingly. The total exercise and rest time before tracer injection was ~6-140 
7 minutes followed by the post-injection exercise-rest of ~15 minutes. The subjects did not 141 
report pain or discomfort before, during, or immediately subsequent to the exercise protocol. 142 
EMG from lower leg muscles was recorded during the exercise. At the cessation of the exercise 143 
protocol, subjects were moved to the PET scanner on a wheelchair and scanning started within 144 
5 minutes. Repeated blood sampling for plasma radioactivity determination was started 145 
simultaneously with the tracer injection and continued until the end of the PET scan. Magnetic 146 
Resonance Imaging (MRI) was performed within an hour after the PET scanning.  147 
 EMG and Force Data Acquisition and Analyses  148 
Electromyographic data were recorded using conventional bipolar SEMG electrodes from both 149 
legs. Silver-Silver Chloride Ambu Blue Sensor N electrodes (Ambu A/S, Ballerup, Denmark) with 150 
an inter-electrode distance of 22 mm were placed, according to the SENIAM recommendations 151 
(Hermens et al., 1999), over soleus, medial gastrocnemius (MG), and lateral gastrocnemius (LG) 152 
muscles. The electrodes on flexor hallucis longus (FHL) were placed after locating the muscle 153 
behind the medial malleolus by manual palpation. Furthermore, an indifferent electrode was 154 
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secured on the right medial malleolus to reduce noise signal. EMG data were detected online 155 
via EISA (bandwidth 10 Hz to 1 kHz per 3 dB) EMG detection system (model: 16-2, University of 156 
Freiburg, Germany) at a measurement frequency of 1000 Hz. Signal was pre-amplified with a 157 
factor of 200 by an integrated preamplifier in the cables. Analogue-to-digital conversion of EMG 158 
and force data was completed via Power 1401 high-performance multi-channel data acquisition 159 
interface (CED Ltd., Cambridge, England). Compatible Signal 4.0 software (CED Ltd., Cambridge, 160 
England) was used to record, reduce, and analyze data. EMG signals from one set of five 161 
contractions were recorded separately for each leg from the beginning, middle, and end of the 162 
exercise protocol. That resulted in data comprising three sets of five submaximal isometric 163 
contractions each for either leg.  164 
EMG data was differentiated by high-pass filtering (second-order Butterworth filter, 165 
12dB/octave) with a cutoff frequency of 10Hz to remove noise signal and correct DC offset. 166 
Root Mean Square (RMS) amplitude of each muscle was calculated from a 3-second epoch 167 
during the middle of a 5-second submaximal isometric contraction. This RMS was normalized to 168 
the RMS amplitude from a 1-second time window during MVC. Additionally, SOL-to-FHL, MG-169 
to-FHL, and LG-to-FHL submaximal EMG muscle ratios were computed by dividing the 170 
respective normalized RMS.  171 
Plantarflexion Force: Isometric ankle plantarflexion force was measured by an in-house custom-172 
built portable force transducer (University of Jyväskylä, Finland) (Fig. 2). The transducer plate 173 
was secured with steel chains, which were connected to the seat-back creating a rigid frame. 174 
Mean absolute ankle plantarflexion force during the submaximal isometric contractions was 175 
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calculated along with the MVC force. Force data recording was also done via Signal 4.0 (CED 176 
Ltd., Cambridge, England) in synch with EMG. 177 
Because neither SEMG, nor plantarflexion force showed decline during the exercise protocol, 178 
their average was taken to represent each muscle’s electrical activity and force level. 179 
Image Acquisition 180 
PET: The participants were positioned supine in the scanner with radioactive markers secured 181 
on lateral malleoli and medial femoral condyles to enable alignment of PET and MRI images. A 182 
CTI-Siemens ECAT EXACT HR+ (Siemens, Knoxville, TN, USA) PET scanner was used to scan the 183 
legs in four adjacent regions covering the whole leg from toes to upper thigh. The emission scan 184 
of each region lasted for approximately five minutes and was followed by a transmission scan 185 
lasting about two minutes per region. Altogether the scan of the legs with transition time 186 
between the regions took ~32 minutes.  187 
MRI scanning was performed with 1.5 T Philips Intera MRI (Philips Healthcare, Eindhoven, The 188 
Netherlands) for both legs. Lipid pills for anatomical reference were taped to the same 189 
anatomical landmarks as were used in the PET. 190 
Image Analysis 191 
After the PET images were corrected for decay, parametric fractional uptake rate (FUR) images 192 
were computed using the PET image data and the individual input function (plasma 193 
radioactivity data) as described previously (Fujimoto et al., 2003; Kemppainen et al., 2002). The 194 
regions of interest (ROIs) were then drawn, at an interval of 1 cm of muscle thickness, on the 195 
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transverse plane FUR images to include the whole individual muscle using Carimas 2.0 software 196 
(Turku PET Centre, University of Turku, Finland). All drawings were made by the same 197 
investigator (TM) to avoid inter-observer differences. Glucose FUR values were obtained for 198 
soleus, medial and lateral gastrocnemii, FHL, and the Achilles tendon. These values were further 199 
converted to glucose uptake values using the following formula: 200 
                                   
                    
                                
 
Plasma glucose level was obtained from the plasma sampling during the study. The lumped 201 
constant is the value that takes into account differences in the uptake of glucose and 18F-FDG 202 
from the blood and it has been shown to be 1.2 for skeletal muscle (Kelley et al., 1999; 203 
Peltoniemi et al., 2000). Tissue density was acquired from Report of the Task Group on 204 
Reference Man (Snyder et al. 1975).  205 
In order to examine the relative contribution of various plantarflexors, SOL-to-FHL, MG-to-FHL, 206 
and LG-to-FHL muscle GU ratios were calculated, as in EMG. MRI images were used as an 207 
anatomical reference to delineate the targeted muscles for ROIs drawings on PET images. 208 
Statistical analysis 209 
Normality of the data was explored using Shapiro-Wilk test, which revealed that some variables 210 
had normal distribution, but not all. Mann–Whitney U test or independent samples T-test were 211 
used accordingly to compare the skeletal muscle glucose uptake and electrical muscle activity 212 
of the tendon-pain and healthy groups. Between-leg comparison within a group was analyzed 213 
with either Wilcoxon signed rank test or paired samples T-test. IBM SPSS 20.0 (IBM Corporation, 214 
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New York, USA) software was used for all statistical analyses. Alpha (α) level of significance was 215 
set at a P value of 0.05. The results are expressed as mean (SD) (standard deviation). 216 
Additionally, effect size (ES) was calculated for both within- and between-group comparisons. 217 
RESULTS 218 
Force: Maximal plantarflexion force was greater in NO-PAIN compared to PAIN [1250 (192) N 219 
vs. 1101 (176) N; P<0.05; ES = 0.8]. Since both control legs displayed similar force [1133 (236) N 220 
vs. 1129 (192) N], their average [1131 (191) N] was used for between-group comparisons.  221 
The 30 % MVC target plantarflexion force used in the isometric exercise protocol was greater in 222 
NO-PAIN versus PAIN [369 (52) N vs. 325 (46) N; P<0.005; ES = 0.8]. Corresponding value for 223 
CTRL was 349 (56) N, which did not differ significantly from PAIN and NO-PAIN. 224 
Electromyography 225 
EMG during exercise: Within the tendinopathy subjects, EMG (%MVC) for soleus was higher in 226 
PAIN compared to NO-PAIN (P<0.05; ES = 1.7). Similarly, EMG magnitude in FHL was greater in 227 
PAIN (P<0.05; ES = 0.2). Soleus displayed greater activity in PAIN (P<0.05; ES = 1.4) compared to 228 
CRTL while FHL on the NO-PAIN side had lower (P<0.05; ES = 0.5) EMG level than CTRL (Fig. 3).  229 
EMG ratios: During the submaximal exercise, MG-to-FHL ratio in PAIN was significantly smaller 230 
than NO-PAIN within the tendinopathy group (P<0.05; ES = 0.6). Other two ratios were similar 231 
across the legs. CTRL had smaller SOL-to-FHL ratio (P<0.05; ES = 1.7) than PAIN while MG-to-FHL 232 
ratio was significantly higher (P<0.05; ES = 0.5) in NO-PAIN compared to CTRL (Fig. 4).  233 
Muscle-Tendon Glucose Uptake 234 
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Representative MRI and PET images from a patient in the study are shown in Fig. 5. In the 235 
patient group, all three triceps surae muscles showed a tendency towards a lower glucose 236 
uptake in NO-PAIN compared to NO-PAIN (Fig. 6), while the opposite was seen for FHL. Achilles 237 
tendon GU rate was identical across the two legs.  238 
Both PAIN and NO-PAIN tended to have greater muscle GU rate compared to CTRL. In the case 239 
of Achilles tendon, both PAIN (ES = 1.2) and NO-PAIN (ES = 1.0) had significantly higher GU rate 240 
than CTRL (P<0.05). Glucose uptake rate ratios between the superficial and deep plantarflexors 241 
revealed no significant differences between legs or groups. 242 
 243 
DISCUSSION 244 
In chronic Achilles tendinopathy patients, the stronger NO-PAIN leg exercised with less relative 245 
EMG than the PAIN leg during the submaximal exercise. Muscle glucose uptake rate tended to 246 
be higher in the patient legs compared to the control legs. The overall EMG findings showed a 247 
greater relative activity in the symptomatic leg versus the asymptomatic leg, which 248 
corresponded to our hypothesis. On the other hand, the GU results suggested similar behavior 249 
between the two patient legs, which contradicted our hypothesis. These dissimilar findings by 250 
the two fundamentally different methodologies are further discussed below. 251 
In line with our hypothesis, the maximal isometric plantarflexion force was significantly 252 
greater in NO-PAIN compared to PAIN. We also expected a similar discrepancy between PAIN 253 
and CTRL but no difference was evident. One explanation may be that the subjects in the 254 
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patient group were physically more active and had therefore about 10 % stronger legs than 255 
CTRL despite being age-weight-height matched. For obvious reasons, the differences in the 256 
MVC were also reflected in the target force levels for the submaximal isometric exercise.  257 
Unsurprisingly, FHL demonstrated greater relative myoelectric activity in the 258 
symptomatic leg versus the asymptomatic leg. It was expected that reduced triceps surae input 259 
due to an injured Achilles tendon would lead to a compensatory rise in the activity of 260 
corresponding secondary plantarflexors, such as the FHL. Surprisingly, however, soleus in the 261 
symptomatic leg was also found to have more activity (~67 %) than its asymptomatic 262 
counterpart, and the mechanism for this increase remains unknown. However, it must be noted 263 
that SOL-to-FHL ratio was not significantly different between the two patient legs due to a 264 
concomitant rise in the activity of both muscles in the symptomatic leg.  The soleus muscle also 265 
happened to be the most active of the four muscles in the symptomatic leg whereas the MG 266 
was the most active in the asymptomatic leg. Additionally, the soleus muscle in the 267 
symptomatic leg showed more relative activity than healthy controls despite the other three 268 
muscles being comparable in their activity levels. In contrast, all triceps surae components of 269 
the asymptomatic leg behaved in a similar manner to that of controls. This scenario, except for 270 
the soleus, is in accordance with our hypothesis that EMG activity of triceps surae components 271 
in PAIN will be similar to that of NO-PAIN and CTRL. Similarly, the assumption that TS muscles of 272 
NO-PAIN in the tendon pain group would behave similarly to the CTRL was also found to be 273 
true.  274 
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In the past, behavior of the TS muscle EMG during submaximal isometric contractions 275 
has been reported in the literature. EMG (%MVC) of soleus, MG, and LG at the beginning of a 276 
sustained unilateral submaximal (40 %MVC) isometric exercise was shown to be ~43%, ~33%, 277 
and ~28% respectively in older healthy male subjects (Mademli & Arampatzis, 2005). In 278 
dynamic exercises Kinugasa et al. (2005) reported that EMG activities were 49% (Sol), 64-88 % 279 
(MG), and 57 % (LG) in repetitive, single leg calf-raise exercise. In the same study, MRI 280 
technique revealed that only ~46 % of MG, in terms of muscle volume, was activated compared 281 
to ~35 % in the case of soleus and LG (Kinugasa et al., 2005). In our much younger healthy 282 
controls, values were ~26 % (Sol), ~33 % (MG), and ~21 % (LG). On the other hand, muscles in 283 
the injured legs of our patient group yielded the values of ~38 % (Sol), ~32 %, (MG), and ~18 % 284 
(LG). 285 
Contrary to the findings using SEMG, plantarflexor muscle GU rate showed no significant 286 
differences in either absolute or relative terms. It was expected that the glucose uptake of the 287 
TS muscle of PAIN would be appreciably lower than CTRL. However, CTRL had a tendency for 288 
lower GU rate than both PAIN and NO-PAIN. In the tendon pain group, despite a greater 289 
absolute force in NO-PAIN, no significant differences in GU rate was observed between the two 290 
legs although there was a trend towards a higher uptake in NO-PAIN triceps surae. In the case 291 
of FHL, the GU rate was expected to be higher in PAIN as an indicator of a compensatory 292 
increment in the contribution from the deep plantarflexors. Although the trend of glucose 293 
uptake behavior of all muscles was in line with our expectations, the differences were not 294 
significant for our hypothesis to be accepted.  295 
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While there are no previous studies on the glucose uptake behavior of various 296 
plantarflexors, under submaximal isometric conditions, in Achilles tendinopathy patients, a 297 
study on quadriceps femoris muscle reported GU of 7.5 μmol*100g-1*min-1 in cycling exercise 298 
[91 W) at 30% VO2max (Kemppainen et al., 2002). This is more than twice the GU of 299 
plantarflexors in our study. Another study (Hannukainen et al., 2005) reported the values of 300 
~4.5 μmol*100g-1*min-1 using the same protocol as Kemppainen et al. at (77 W). Yet another 301 
study, comparing GU response to exercise in trained and untrained men, reported a quadriceps 302 
femoris GU of ~5 μmol*100g-1*min-1 in untrained men during cycle ergometry at 30% VO2max 303 
(Fujimoto et al., 2003).  304 
In the Achilles tendon itself, GU rate was significantly lower than that of muscles’ in 305 
both groups ranging from 1.0 to 1.5 μmol*100g-1*min-1 in CTRL and PAIN respectively. In the 306 
Achilles tendinopathy patients, the tendon GU rate in both legs was significantly higher than in 307 
the control group. While the higher GU in the asymptomatic tendon can be explained by 308 
greater force transmission, the higher metabolic activity in the symptomatic tendon is more 309 
difficult to explain. Achilles tendinopathy is known to be associated with increased cell count 310 
(Pingel et al. 2012) which might be responsible for the observed higher glucose uptake. 311 
Although inflammation could theoretically have a role in the finding, most histological (Movin 312 
et al., 1997), biochemical (Alfredson et al., 2001), and microdialysis (Alfredson et al., 1999) 313 
studies have concluded that inflammation is absent in Achilles tendinopathy. Even though 314 
microdialysis technique has demonstrated a lack of appreciable GU in the peritendinous tissue 315 
of healthy Achilles tendons (Langberg et al., 1999), an FDG-PET case study has shown an 316 
abnormally high Achilles tendon glucose uptake in the case of Achilles tendinopathy (Huang et 317 
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al., 2006), which corroborates the findings of the present study. The underlying mechanism for 318 
the higher metabolic demand in the symptomatic Achilles tendinopathy is unknown, but may 319 
relate to an increase in cell density.  320 
Previously, Hannukainen et al. (2005) published the Achilles tendon GU of well under 1 321 
μmol*100g-1*min-1 during cycle ergometry at 30% VO2max and it stayed constant as the exercise 322 
intensity was increased to 75% VO2max. However, it must be noted that while the plantarflexion 323 
task in the present study caused direct strain to Achilles tendon, cycling used by Hannukainen 324 
and colleagues has only a limited impact on Achilles tendon. A case study involving a 30-year 325 
old male reported a 2-fold increase in Achilles tendon glucose uptake, as a result of exercise, 326 
compared to the resting contralateral leg (Kalliokoski et al., 2007). A comparable increase was 327 
also observed in glucose uptake in patellar and quadriceps tendons during one-leg dynamic 328 
knee extension exercise protocol (Kalliokoski et al. 2005).  329 
We examined the relative contributions of primary plantarflexors (triceps surae) to a 330 
secondary plantarflexor (FHL) by calculating SOL-to-FHL, MG-to-FHL, and LG-to-FHL muscle 331 
ratios. Regarding muscle GU ratios, there were no differences observed across legs or groups. 332 
Concerning EMG, the ratios were closest to 1 signifying balanced contribution between deep 333 
and superficial plantarflexors in healthy controls. However, in patients there was no systematic 334 
pattern in this parameter although significant difference was observed between legs in MG-to-335 
FHL ratio. This was due to a significantly lower FHL activity in NO-PAIN. While comparing the 336 
two groups, PAIN had significantly greater SOL-to-FHL ratio than CTRL. This finding contradicts 337 
with the observations based on muscle displacement between healthy and Achilles tendon 338 
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injury patients. Finni et al. (2006) reported that SOL-to-FHL muscle peak displacement ratios 339 
were greater in healthy compared to the injured without differences between the legs within 340 
the patients. It should be noted that different methodological factors can play a role in these 341 
two contradictory findings. While EMG ratios are affected by uncertainty of muscle activation 342 
during MVC, the muscle displacement ratios are influenced by muscle architecture and 343 
mechanics. What are similar to both studies are the large individual differences between the 344 
subjects potentially suggesting a wide range of individual coordinative strategies within the 345 
plantarflexors. 346 
Limitations of the study: Assumption made in this study that all compartments of TS 347 
muscle were fully activated when MVC was recorded warrants caution while making inferences 348 
based on the findings. Similarly, contractions at 30% MVC level do not imply that each muscle 349 
was activated at 30% of its capacity. The EMG results reported here are normalized to the EMG 350 
RMS during the MVC and, thus, only represent the relative activation of the muscles. The same 351 
argument applies to the muscle EMG ratios. Furthermore, although the exercise protocol could 352 
theoretically be performed during the PET scan, we chose to do the exercise before the PET 353 
scan. This same protocol has been recently applied in several other experiments (Fujimoto et 354 
al., 2003; Hannukainen et al., 2005; Kemppainen et al., 2002). 355 
In conclusion, although surface EMG revealed major inter-leg and group differences in 356 
the use of triceps surae muscle, glucose uptake, reflecting the function of the entire muscle, did 357 
not manifest significant differences between healthy subjects and chronic Achilles tendon pain 358 
patients. In the case of Achilles tendon, both legs in the patient group displayed significantly 359 
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higher GU compared to the healthy tendons. These differential results from local and global 360 
measures call attention to the complexity of muscle-tendon function in three-dimensional 361 
space. 362 
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FIGURES LEGENDS: 
Figure 1. Schematic diagram of experimental protocol. After subject preparation and warm-up 
exercise, radioactive tracer ([18F]-Fluorodeoxyglucose) was administered followed by isometric 
submaximal exercise protocol. Positron emission tomography was performed after the exercise 
which preceded magnetic resonance imaging. 
 
Figure 2. Experimental setup. A subject is pressing with her left foot against the force 
transducer during a submaximal contraction. Intravenous catheters can be seen on both arms 
for blood sampling and tracer injection. Also visible are some of the SEMG electrodes 
connected to the data acquisition device and an electronic goniometer around the right ankle. 
 
Figure 3. Comparison of EMG (%MVC) values during submaximal isometric contractions for 
both study groups. (Sol = Soleus, MG = Medial Gastrocnemius, LG = Lateral Gastrocnemius, FHL 
= Flexor Hallucis Longus)  
* Significant difference between PAIN and CTRL (P<0.05). 
# Significant difference between NO-PAIN and CTRL (P<0.05). 
! Significant difference between PAIN and NO-PAIN (P<0.05). 
 
Figure 4. Comparison of selected plantarflexor muscle EMG ratios during submaximal isometric 
contractions for both study groups. (TS = Triceps Surae, MG = Medial Gastrocnemius, Sol = 
Soleus, LG = Lateral Gastrocnemius, FHL = Flexor Hallucis Longus) 
* Significant difference between PAIN and CTRL (P<0.05). 
# Significant difference between NO-PAIN and CTRL (P<0.05). 
! Significant difference between PAIN and NO-PAIN (P<0.05). 
 
Figure(s)
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Figure 5. Images from a tendon pain patient: A) an axial MRI section with region of interest 
(ROI) drawing on triceps surae muscle of the left leg, B) same image superimposed with PET 
sinograms. 
Figure 6. Muscle glucose uptake comparison for Tendon pain group and Healthy control group. 
(Sol = Soleus, MG = Medial Gastrocnemius, LG = Lateral Gastrocnemius, FHL = Flexor Hallucis 
Longus, AT = Achilles Tendon) 
* Significant difference between PAIN and CTRL (P<0.05). 
# Significant difference between NO-PAIN and CTRL (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
FIGURES: 
 
Figure 1 
 
 
 
 
 
 
 
 
4 
 
 
Figure 2 
 
 
 
 
 
 
 
5 
 
 
Figure 3 
 
 
 
 
 
 
6 
 
 
Figure 4 
 
 
 
 
 
 
7 
 
 
Figure 5 
 
 
 
 
 
 
 
8 
 
 
Figure 6 
 
